Prophylactic treatment of asthma;Tratamento profilático da asma

Jornal de Pediatria

Volumn 78, Issue SUPPL. 2, 2002, Pages

  De Moura, Jose Augusto Rubim ^a,c   Camargos, Paulo Augusto Moreira ^a   De Blic, Jacques ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AEROCHAMBER; ANTIASTHMATIC AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; METHYLXANTHINE; NEBUCHAMBER; SALBUTAMOL; VOLUMATIC;

ASTHMA; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DEVELOPING COUNTRY; DRUG CHOICE; FACTUAL DATABASE; HUMAN; IMMUNOTHERAPY; MEDICAL NEBULIZER; MEDLINE; META ANALYSIS; PROPHYLAXIS; REVIEW; TREATMENT OUTCOME;

EID: 0036868106     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. National Heart, Lung, and Blood Institute, National Institutes for Health. Global Strategy for Asthma Management and Prevention: NHLBI/WHO Workshop Report. Bethesda: National Institutes of Health; revised 2002.
2. Tasche MJ, Uijen JH, Bernsen RM, de Jongste JC, van der Wouden JC. Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: A systematic review. Thorax 2000;55:913-20.
3. Calpin C, Macarthur C, Stephens D, Feldman W, Parkin PC. Effectiveness of prophylactic inhaled steroids in childhood asthma: A systemic review of the literature. J Allergy Clin Immunol 1997;100:452-57.
4. 2 agonists bronchodilators in asthma BMJ 2001;323:901-5.
5. Brocklebank D, Wright J, Cates C. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma BMJ 2001;323:896-900.
6. Dompeling E, Oudesluys-Murphy AM, Janssens HM, Hop W, Brinkman JG, Sukhai RN, et al. Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic charge. Arch Dis Child 2001;84:178-82.
7. Calpin C, Macarthur C, Stephens D, Feldman W, Parkin PC. Effectiveness of prophylactic inhaled steroids in childhood asthma: A systemic review of the literature. J Allergy Clin Immunol 1997;100:452-57.
8. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998;157(3 Pt 2):S1-53.
9. Holt S, Suder A, Weatherall M, Cheng S, Shirtcliffe P, Beasley R. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: Meta-analysis. BMJ 2001;323:253-6.
10. Skoner DP. Balancing safety and efficacy in pediatric asthma management. Pediatrics 2002;109:381-92.
11. Sharek PJ, Bergman DA. The effect of inhaled steroids on the linear growth of children with asthma: A meta-analysis. Pediatrics 2000;106(1):E8
12. Allen DB. Inhaled corticosteroid therapy for asthma in preschool children: Growth issues. Pediatrics 2002;109:373-80.
13. Reilly SM, Hambleton G, Adams JE, Mughal MZ. Bone density in asthmatic children treated with inhaled corticosteroids. Arch Dis Child 2001;84:183-4.
14. Dubus JC, Marguet C, Deschildre A, Mely L, Le Roux P, Brouard J, et al. Local side-effects of inhaled corticosteroids in asthmatic children: Influence of drug, dose, age, and device. Allergy 2001;56:944-8.
15. Agertoft L, Larsen FE, Pedersen S. Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide. Eur Respir J 1998;12:130-5.
16. Spahn JD, Szefler SJ. Childhood asthma: New insights into management. J Allergy Clin Immunol 2002;109:3-13.
17. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-81.
18. Simons FE. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med 1997;337:1659-65.
19. Bisgaard H. Long-acting beta2-agonists in management of childhood asthma: A critical review of the literature. Pediatr Pulmonol 2000;29:221-34.
20. Russell G, Williams DA, Weller P, Price JF. Salmeterol xinafoate in children on high dose inhaled steroids. Ann Allergy Asthma Immunol 1995;75:423-8.
21. Lenney W, Pedersen S, Boner AL, Ebbutt A, Jenkins MM. Efficacy and safety of salmeterol in childhood asthma. Eur J Pediatr 1995;154:983-90.
22. Weinstein S, Pearlman DS, Bronsky EA. Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma. Ann Allergy Asthma Immunol 1998;81:51-8.
23. Verberne AA, Hop WC, Bos AB, Kerrebijn KF. Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children. J Allergy Clin Immunol 1993;91 (1 Pt 1):127-34.
24. Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, Le Souef P, Santanello N, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001;108:E48.
25. Simons FER, Villa JR, Lee BW, Teper AM, Lyttle B, Aristizabal G, et al. Montelukast added to budesonide in children with persistent asthma: A randomised, double-blind, crossover study. J Pediatr 2001;138:694-8.
26. Knorr B, Matz J, Bernstein JA, Nguyen H, Seidenberg BC, Reiss TF, et al. Montelukast for chronic asthma in 6- to 14-year-old children: A randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA 1998;279:1181-6.
27. Warner JO. The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood. Allergy 2001;56 Suppl 66:22-9.
28. Ducharme FM. Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: Systematic review of current evidence BMJ 2002;324:1545.
29. Leflein JG, Szefler SJ, Murphy KR, Fitzpatrick S, Cruz-Rivera M, Millerand CJ, et al. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: Results of a randomized outcomes trial. Pediatrics 2002;109:866-72.
30. British Asthma Guidelines Coordinating Committee. British guidelines on asthma management: 1995 Review and position statement. Thorax 1997;52 Suppl:1-24.
31. Rona RJ. Asthma and poverty. Thorax 2000;55:239-44.
32. Watson JP, Lewis RA. Is asthma treatment affordable in developing countries? Thorax 1997;52:605-7.
33. Cabral AL, Carvalho WA, Chinen M, Barbiroto RM, Boueri FM, Martins MA. Are International Asthma Guidelines effective for low-income Brazilian children with asthma? Eur Respir J 1998;12:35-40.
34. Lasmar L, Goulart E, Sakurai E, Camargos P. Fatores de risco para hospitalização de crianças e adolescentes asmáticos em Belo Horizonte (MG). Rev Saude Publica 2002 (no prelo).
35. Fontes MJF. Síndrome Sibilante e Asma Brônquica: Proposta de Atendimento em Crianças e Adolescentes Através da Parceria SUS/UFMG [tese]. Universidade Federal de Minas Gerais; 2002.p.96.
36. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98:1051-7.